Results 111 to 120 of about 297,519 (217)

Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. [PDF]

, 2012
BACKGROUND: Dengue hemorrhagic fever (DHF) is a severe form of dengue, characterized by bleeding and plasma leakage. A number of DHF risk factors had been suggested.
Kee Seng Chia, Lee, VJ, Vernon J. Lee (134839), Salim, A., Salim, Agus, Lye, D.C., Martin L Hibberd, Leo Yee Sin, Chia Kee Seng, Hibberd Martin L., Chia, K.S., Chia, Kee Seng, Pang Junxiong, Junxiong Pang, Leo, Yee Sin, Lee, Vernon J, David C. Lye (102016), Pang, Junxiong, Junxiong Pang (167203), Lee, V.J., Hibberd, ML, Lee Vernon J., Lye David C., Leo, Y.S., Leo, YS, Yee Sin Leo (134858), Salim, A, David C Lye, Pang, J., Salim Agus, Vernon J Lee, Martin L. Hibberd (167212), Hibberd, Martin L, Yee Sin Leo, Chia, KS, Agus Salim, Pang, J, Agus Salim (167207), Hibberd, M.L., Lye, DC, Kee Seng Chia (28193), Lye, David C   +41 more
core   +2 more sources

An international study on emerging arboviral infections and blood safety

Transfusion, Volume 66, Issue 9, Page 1786-1799, September 2026.
Abstract Background Emerging and re‐emerging arboviral infections are a risk to blood safety. We conducted an international survey on how blood establishments respond to current and future arbovirus threats. Study Design and Methods A questionnaire on arbovirus donor deferral strategies, pathogen reduction, and donation screening was distributed to ...
Piya Rajendra, Helen M. Faddy, Daniel Candotti, Carolina B. Bub, Jose M. Kutner, Steven J. Drews, Carmen L. Charlton, Sheila F. O'Brien, Wai‐Chiu Tsoi, Michel‐Andres Garcia‐Otalora, Claire Reynolds, Tuulia Palukka, Riikka Lehtisalo, Ruth Offergeld, Axel Seltsam, Marijke Weber‐Schehl, Nahid Chenarsabz, Naoko Goto, Sung‐Chan Park, So‐Yong Kwon, Ryanne Lieshout‐Krikke, Aneta Kopacz, Ewa Sulkowska, Oana‐Alexandra Șerban, Simona Ruta, Eugene Zhiburt, Maha Badawi, Josephine Mitchel, Ute Jentsch, Ángel Luis Pajares Herraiz, Ana Lafuente Guijosa, Gülşen Özkaya Şahin, Christoph Niederhauser, Marion C. Lanteri, Brian Custer, Galen Conti, Anthea Cheng, Shannah Secret, Peter Simmonds, Heli Harvala, on behalf of the Virology subgroup of the ISBT WP‐TTID   +40 more
wiley   +1 more source

A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis. [PDF]

Vaccines (Basel), 2023
Ngwe Tun MM, Nwe KM, Balingit JC, Takamatsu Y, Inoue S, Pandey BD, Urano T, Kohara M, Tsukiyama-Kohara K, Morita K.   +9 more
europepmc   +1 more source

Modelling the control strategies against dengue in Singapore. [PDF]

, 2007
Notified cases of dengue infections in Singapore reached historical highs in 2004 (9459 cases) and 2005 (13,817 cases) and the reason for such an increase is still to be established.
LOPEZ, L. F., Coutinho, FAB, Lopez, LF, Ma, S, Coutinho, F.A.B., Burattini, M.N., Chow, A, Massad, E, COUTINHO, F. A. B., CHEN, M., MA, S., Goh, KT, MASSAD, E., Chen, M, Goh, K.T., CHOW, A., BURATTINI, M. N., GOH, K. T., Lopez, L.F., Burattini, MN   +19 more
core   +1 more source

Vaccination against dengue fever for travellers

Swiss Medical Weekly
Dengue fever, endemic to most tropical and subtropical countries, is a major cause of illness in travellers, but severe dengue, hospitalisation and death are considered rare in this population.
Gilles Eperon, Cornelia Staehelin, Serge de Vallière, Olivia Veit   +3 more
doaj   +1 more source

Dengue Vaccine Development and Deployment into Routine Immunization

Vaccines
Dengue has emerged as a significant global health threat. Despite decades of research, only two dengue vaccines—CYD-TDV (Dengvaxia) and TAK-003 (Qdenga)—have been licensed to date, with limited implementation.
Annelies Wilder-Smith, Thomas Cherian, Joachim Hombach   +2 more
doaj   +1 more source

Efficacy of Dengue Vaccines in the Prevention of Severe Dengue in Children: A Systematic Review. [PDF]

Cureus, 2022
Foucambert P, Esbrand FD, Zafar S, Panthangi V, Cyril Kurupp AR, Raju A, Luthra G, Shahbaz M, Almatooq H, Khan S.   +9 more
europepmc   +1 more source

ACIP Dengue Vaccines Workgroup considerations and next steps [PDF]

Dengue-04-Waterman-508 ...

core  

Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines. [PDF]

Front Immunol, 2022
Hou J, Ye W, Chen J.
europepmc   +1 more source

Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.

PLoS Pathogens, 2019
The need for improved dengue vaccines remains since the only licensed vaccine, Dengvaxia, shows variable efficacy depending on the infecting dengue virus (DENV) type, and increases the risk of hospitalization for severe dengue in children not exposed to ...
Maria Beatriz Borges, Renato Sergio Marchevsky, Renata Carvalho Pereira, Ygara da Silva Mendes, Luiz Gustavo Almeida Mendes, Leonardo Diniz-Mendes, Michael A Cruz, Ouafaâ Tahmaoui, Sébastien Baudart, Marcos Freire, Akira Homma, Kirsten Schneider-Ohrum, David W Vaughn, Yannick Vanloubbeeck, Clarisse Lorin, Marie-Pierre Malice, Elena Caride, Lucile Warter   +17 more
doaj   +1 more source